SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 
“Clasado never at any point sought to make any misleading or exaggerated claims.”

UK clams Clasado prebiotic claims; cans ‘transition period’ argument

By Shane Starling+

04-Jun-2014
Last updated on 04-Jun-2014 at 16:01 GMT2014-06-04T16:01:24Z

Bimuno marketing as it appears online today. Clasado is in the process of updating it to comply with the ruling
Bimuno marketing as it appears online today. Clasado is in the process of updating it to comply with the ruling

UK-Jersey prebiotic specialist Clasado has had web-based, gut-immunity claims slapped down by the UK advertising watchdog the Advertising Standards Authority (ASA) which found they were unauthorised under the EU nutrition and health claims regulation (NHCR).

One of the complainants was UK consumer watchdog, Which?.

Clasado, which has been universally rebuffed under the NHCR as have all prebiotic and probiotic players, today issued a statement referencing the research for its Bimuno product and the fact its claim-making was initially mandated as part of a transition period after its latest European Food Safety Authority (EFSA) claim rejection at the end of June 2013.

“The ASA has acknowledged that claims relating to digestive comfort made at the time of the instigation of the investigation were entirely permissible,” the firm said.

“Commission regulation 1017/2013 relating to a previous EFSA opinion specifically set out the provision of a six month transition period for existing digestive comfort claims.”

Such a transition period would apply after the opinion was written into the Official Journal of the European Union, meaning the claims could continue until May 13 this year, Clasado posited.

None of that held any sway with the ASA which said the web-based claims exaggerated the claim, “Bimuno may reduce intestinal discomfort", that could have applied to any approved transition period.

It told Clasado to cease making unauthorised disease-base claims.

Despite stating it had, “never at any point sought to make any misleading or exaggerated claims”, Clasado said it was, receiving advice from the regulatory bodies to adjust claims on its consumer website.”

Rejected claim making

The Clasado claims included,“Helps stop bad bacteria from getting a hold" and, “helps encourage and sustain a healthy level of your gut's 'good bacteria' (Bifidobacteria) helping to prevent 'bad bacteria' from becoming established.”

The ASA said those claims were unfounded along with others on a page titled, "BIMUNO RESEARCH AND CLINICAL TRIALS" which summarised varying pieces of research including placebo-controlled, double-blind intervention trials.

Other pages were also censored including one that stated, “Bimuno users experience a significant increase in their gut Bifidobacterium within just 7 days.”

But the ASA said European Commission and UK Department of Health (DoH) guidance on the matter was clear: That even references to the words prebiotic and probiotic are implied, unauthorised health claims and therefore forbidden.

It therefore concluded, “that the ad contained health claims and reduction of disease risk claims for Bimuno Prebiotic Powder and TRAVELAID that were not authorised on the EU Register, nor were they a variation of the rejected claim to which the transition period applied, and the ad therefore breached the Code in those regards.”

Clasado’s rejected EFSA dossier focused on five human intervention studies, three non-human studies and one systematic review.

Bimuno GOS is a blend of β-galacto-oligosaccharides, derived from lactose conversion using Bifidobacterium bifidum NCIMB 41171 enzymes.

The full ASA ruling is here .

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars